Contemporary Therapy e-Monograph

Contemporary Therapy for HL: Where Are We Now?
Contemporary Therapy for HL: Where Are We Now?
Franco Cavalli, MD, FRCP; Tim Illidge, PhD, MRCP, FRCR, FRCPath; Peter Borchmann, MD
Release Date: October 16, 2015
Expiration Date: October 16, 2016

This activity has been designed to offer you the latest therapeutic insights for the management of Hodgkin lymphoma (HL) from current practice to the status of ongoing clinical trials.

Provided by MediCom Worldwide, Inc.
This activity has been supported by educational grants from Takeda Oncology and Seattle Genetics, Inc. MediCom Worldwide, Inc. acknowledges support from The Leukemia & Lymphoma Society
View Only, CE ExpiredView Only, No Credit

MediCom Worldwide, Inc. would like to recognize and thank Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics for their educational support. To better serve the needs of our audience, is now

©2020 MediCom Worldwide, Inc. All rights reserved